首頁 > 市場調查報告書 > 製藥

生物製劑

市場調查報告書

商品編碼

2092699

病毒載體及質體DNA生產市場：依產品類型、工作流程、應用、最終用途、國家及地區分類－產業分析、市場規模、市場佔有率及2026年至2033年預測

Viral Vectors and Plasmid DNA Manufacturing Market, By Product Type, By Workflow, By Application, By End-Use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2026-2033

出版日期: 2026年06月24日 | 出版商:

AnalystView Market Insights | 英文 340 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2025 年，病毒載體和質體DNA 生產市場價值將達到 65.902 億美元，並將在 2026 年至 2033 年期間以 15.1% 的複合年成長率成長。

病毒載體和質體DNA的生產涉及建構專門的遺傳物質，以支持基因治療、細胞治療、疫苗和其他先進生物醫學應用的發展。質體DNA作為遺傳訊息的載體，通常是病毒載體生產的基礎。病毒載體是經過精心改造的病毒，旨在將治療性基因遞送到特定細胞，同時最大限度地降低致病風險。

病毒載體與質體DNA生產市場－市場動態

細胞療法、基因療法、下一代疫苗的進步以及自動化生產過程的日益普及，預計將推動市場需求。

基因療法、細胞療法和先進疫苗技術的發展是病毒載體和質體DNA生產市場的主要驅動力。隨著生物技術和製藥公司致力於開發精準醫療，透過基因改造和標靶干預治療疾病，對可靠的病毒載體和質體DNA的需求持續成長。這些產品是向細胞導入遺傳物質和開發新療法的基礎工具，在現代生物製藥研發中至關重要。基因組研究表明，目前全球有超過2000種基因和細胞療法候選藥物處於不同的臨床開發階段，為病毒載體和質體DNA的生產創造了巨大的需求。

為了縮短生產週期、最大限度降低污染風險並簡化作業流程，企業正擴大採用自動化生產平台、一次性加工設備和先進的純化技術。此外，合約研發生產機構（CDMO）正透過設施升級、新投資和策略合作來擴大產能，以滿足生物技術和製藥公司日益成長的外包需求。製造商也正在開發新一代病毒載體，旨在提供更高的安全性、標靶化能力和更高的基因傳遞效率。此外，隨著生物技術和製藥公司致力於開發精準醫療，透過基因改造和標靶干預來應對疾病，對可靠的病毒載體和質體DNA的需求持續成長。因此，在持續創新和不斷擴展的治療應用的支持下，預計該市場將保持強勁的成長勢頭。

病毒載體和質體DNA生產市場－細分分析：

全球病毒載體和質體DNA生產市場按產品類型、工作流程、應用、最終用途和地區進行細分。

依產品類型，市場可分為兩大類：病毒載體和質體DNA。預計病毒載體將佔據產品類型中較大的銷售佔有率。病毒載體是細胞療法、基因療法和多種先進疫苗平台的主要遞送載體。病毒載體在將治療基因遞送至目標細胞方面發揮著至關重要的作用，已成為臨床解決方案中不可或缺的一部分。

病毒載體和質體DNA生產市場—區域分析

病毒載體和質體DNA生產市場正呈現強勁的區域性擴張，其中北美憑藉其成熟的生物技術產業、眾多先進治療研發公司、廣泛的研究活動以及對基因和細胞治療項目的大量投資，佔據了市場主導地位。歐洲仍然是一個至關重要的市場，這主要得益於對先進治療技術投資的增加、生物製藥生產能力的提升以及學術機構、研究中心和行業相關人員之間合作的加強。在亞太地區，新建符合GMP標準的生產設施、合約研發生產機構（CDMO）的快速擴張以及生產過程中先進自動化技術的應用，都在推動市場成長。

介紹
北美洲
- 概述
- 主要製造商：北美
- 美國
- 加拿大
歐洲
- 概述
- 主要製造商：歐洲
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 荷蘭
- 瑞典
- 俄羅斯
- 波蘭
- 其他歐洲國家
亞太地區
- 概述
- 主要製造商：亞太地區
- 中國
- 印度
- 日本
- 韓國
- 澳洲
- 印尼
- 泰國
- 菲律賓
- 其他亞太國家
拉丁美洲
- 概述
- 主要製造商：拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 哥倫比亞
- 其他拉丁美洲國家
中東和非洲
- 概述
- 主要生產商：中東和非洲
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 以色列
- 土耳其
- 阿爾及利亞
- 埃及
- 其他中東和非洲國家

第12章主要供應商分析：病毒載體與質體DNA製造業

競爭對手儀錶板
- 競爭基準
- 競爭定位
公司簡介
- Lonza
- Aldevron
- ViroCell Biologics
- Andelyn Biosciences
- VGXI, Inc.
- Avid Bioservices
- Thermo Fisher Scientific
- WuXi Biologics
- Catalent Inc.
- AGC Biologics
- Fujifilm Diosynth Biotechnologies
- Cobra Biologics
- Oxford Biomedica
- Takara Bio
- Charles River Laboratories
- Merck KGaA
- Sartorius
- GenScript Biotech
- RegenxBio Inc.
- SIRION Biotech
- Others

第13章：AnalystView 的全景視圖

簡介目錄

Product Code: ANV6862

Viral Vectors and Plasmid DNA Manufacturing Market size was valued at USD 6,590.2 Million in 2025, expanding to a CAGR of 15.1% from 2026 to 2033.

Viral vectors and plasmid DNA manufacturing involves creating specialized genetic materials that support the development of gene-therapies, cell-based treatments, vaccines, and other advanced biomedical applications. Plasmid DNA acts as a carrier of genetic instructions and often assists as the foundation for producing viral vectors. Viral vectors are carefully engineered viruses designed to transport therapeutic genes into specific cells while minimizing the risk of causing illness.

Viral Vectors and Plasmid DNA Manufacturing Market- Market Dynamics

Growing advancement in cell therapies, gene therapies, next-gen vaccines and adoption of automated manufacturing processes are expected to propel market demand

Development of gene-based therapies, cell-based therapies and advanced vaccine technologies are the major driving factors for Viral Vectors and Plasmid DNA Manufacturing Market. The demand for reliable viral vectors and plasmid DNA is still growing, as biotechnological and pharmaceutical companies focus on developing precision medicines that target diseases through genetic modification and targeted intervention. These products are basic tools for transfection of cells with genetic material and the development of new therapeutic solutions and are indispensable to the development of modern biopharmaceutical research and production. According to the genomic research studies, more than 2,000 gene and cell therapy candidates are currently being evaluated across various stages of clinical development globally, creating significant demand for viral vectors and plasmid DNA production.

To speed up manufacturing cycles, minimize contamination risks and streamline operations, companies are increasingly using automated production platforms, single-use processing equipment and advanced purification technologies. Moreover, contract development and manufacturing organizations (CDMOs) are expanding production capacity through facility upgrades, new investments, and strategic collaborations to support the growing outsourcing needs of biotechnology and pharmaceutical companies. Manufacturers are also advancing the development of next-generation viral vectors designed to offer greater safety, improved targeting capabilities, and enhanced gene delivery efficiency. Further, as biotechnology and pharmaceutical companies focus on developing precision medicines that address diseases through genetic modification and targeted intervention, the need for reliable viral vectors and plasmid DNA continues to rise. The market is therefore expected to maintain strong momentum, supported by ongoing innovation and expanding therapeutic applications.

Viral Vectors and Plasmid DNA Manufacturing Market- Segmentation Analysis:

The Global Viral Vectors and Plasmid DNA Manufacturing Market is segmented on the basis of Product Type, Workflow, Application, End-Use, and Region.

The market is divided into two categories based on Product Type: viral vectors and plasmid DNA. Viral vectors segment anticipated to hold significant revenue share in the product type. Viral vectors are the primary delivery vehicles used in cell therapy, gene therapy, and several advanced vaccine platforms. viral vectors perform the essential function of transporting therapeutic genes into target cells, making them indispensable in clinical solutions.

Viral Vectors and Plasmid DNA Manufacturing Market- Geographical Insights

The viral vectors and plasmid DNA manufacturing market exhibits robust regional expansion, with North America holding a predominant share owing to its mature biotechnology industry, strong presence of advanced therapy developers, extensive research activities, and substantial investments in gene and cell therapy programs. Europe remains a significant market, driven by rising investments in advanced therapeutic technologies, increasing biopharmaceutical manufacturing capabilities, and stronger cooperation between academic institutions, research centers, and industry participants. In the Asia-Pacific region, market growth is being fueled by the construction of new GMP-certified production facilities, the rapid expansion of contract development and manufacturing organizations (CDMOs), and the integration of advanced automation technologies into manufacturing processes.

Canada Viral Vectors and Plasmid DNA Manufacturing Market- Key Insights

Canada is emerging as an important region in the viral vectors and plasmid DNA manufacturing market due to its expanding biotechnology sector, strong research capabilities, and increasing investments in advanced therapeutics. The growing focus on localizing the supply chain for advanced therapies. Organizations are investing in automation, digital manufacturing systems, and scalable production platforms to improve efficiency and reduce dependence on external suppliers. In addition, collaborations between biotechnology firms, research institutions, and healthcare organizations are accelerating innovation and technology transfer. Thus, growing activity in gene-therapy, cell therapy, and vaccine development are generating huge demand for high-quality viral vectors.

Viral Vectors and Plasmid DNA Manufacturing Market- Competitive Landscape:

The competitive landscape of the viral vectors and plasmid DNA manufacturing market is characterized by the expansion of capabilities among biotech companies, specialized manufacturers and contract development and manufacturing organizations (CDMOs) to cater to the rapidly growing field of advanced therapies. Industry players are investing in new manufacturing facilities, upgrading their existing GMP compliant sites and adopting advanced production technologies that improve scalability and efficiency to strengthen their market position. Many organizations are also boosting their manufacturing capacity through strategic partnerships, acquisitions, and biotech company agreements. As more therapies move toward commercialization, the expectation is that there will be a need for reliable, large-scale viral vector and plasmid DNA manufacturing services, which will drive healthy competition.

Recent Developments:

In March 2025, WuXi Biologics introduced the EffiX(TM) microbial expression platform, an advanced high-productivity technology developed to optimize recombinant protein and plasmid DNA production. The platform was designed to improve manufacturing yields, enhance process scalability.

In June 2025, ProBio inaugurated its new 128,000-square-foot Cell and Gene Therapy Center of Excellence in Hopewell, New Jersey. The GMP-compliant facility was established to expand the company's manufacturing capabilities for plasmid DNA, adeno-associated virus (AAV) vectors, and lentiviral vectors, enabling greater support for clinical programs.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL VIRAL VECTORS AND PLASMID DNA MANUFACTURING MARKET KEY PLAYERS

Lonza
Aldevron
ViroCell Biologics
Andelyn Biosciences
VGXI, Inc.
Avid Bioservices
Thermo Fisher Scientific
WuXi Biologics
Catalent Inc.
AGC Biologics
Fujifilm Diosynth Biotechnologies
Cobra Biologics
Oxford Biomedica
Takara Bio
Charles River Laboratories
Merck KGaA
Sartorius
GenScript Biotech
RegenxBio Inc.
SIRION Biotech
Others

GLOBAL VIRAL VECTORS AND PLASMID DNA MANUFACTURING MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2020-2033

Viral Vectors
Adeno-Associated Virus (AAV)
Lentivirus
Adenovirus
Retrovirus
Plasmid DNA
Research-Grade Plasmid DNA
GMP-Grade Plasmid DNA

GLOBAL VIRAL VECTORS AND PLASMID DNA MANUFACTURING MARKET, BY WORKFLOW- MARKET ANALYSIS, 2020-2033

Upstream Manufacturing
Downstream Manufacturing

GLOBAL VIRAL VECTORS AND PLASMID DNA MANUFACTURING MARKET, BY APPLICATION- MARKET ANALYSIS, 2020-2033

Cell Therapy
Gene Therapy
Vaccine Development
Others

GLOBAL VIRAL VECTORS AND PLASMID DNA MANUFACTURING MARKET, BY END-USE- MARKET ANALYSIS, 2020-2033

Pharmaceutical & Biotechnology Companies
CDMOs
Academic & Research Institutes
Others

GLOBAL VIRAL VECTORS AND PLASMID DNA MANUFACTURING MARKET, BY REGION- MARKET ANALYSIS, 2020-2033

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Sweden
Russia
Poland
Denmark
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Philippines
Taiwan
Vietnam
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Iran
Qatar
Rest of MEA

1. Viral Vectors and Plasmid DNA Manufacturing Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Viral Vectors and Plasmid DNA Manufacturing Market Snippet by Product Type
- 2.1.2. Viral Vectors and Plasmid DNA Manufacturing Market Snippet by Workflow
- 2.1.3. Viral Vectors and Plasmid DNA Manufacturing Market Snippet by Application
- 2.1.4. Viral Vectors and Plasmid DNA Manufacturing Market Snippet by End-Use
- 2.1.5. Viral Vectors and Plasmid DNA Manufacturing Market Snippet by Country
- 2.1.6. Viral Vectors and Plasmid DNA Manufacturing Market Snippet by Region
2.2. Competitive Insights

3. Viral Vectors and Plasmid DNA Manufacturing Key Market Trends

3.1. Viral Vectors and Plasmid DNA Manufacturing Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Viral Vectors and Plasmid DNA Manufacturing Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Viral Vectors and Plasmid DNA Manufacturing Market Opportunities
3.4. Viral Vectors and Plasmid DNA Manufacturing Market Future Trends

4. Viral Vectors and Plasmid DNA Manufacturing Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Viral Vectors and Plasmid DNA Manufacturing Market: Impact of Escalating Geopolitical Tensions

5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts

6. Viral Vectors and Plasmid DNA Manufacturing Market Landscape

6.1. Viral Vectors and Plasmid DNA Manufacturing Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Viral Vectors and Plasmid DNA Manufacturing Market - By Product Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Product Type, 2025 & 2033 (%)
- 7.1.2. Viral Vectors
  - 7.1.2.1. Adeno-Associated Virus (AAV)
  - 7.1.2.2. Lentivirus
  - 7.1.2.3. Adenovirus
  - 7.1.2.4. Retrovirus
- 7.1.3. Plasmid DNA
  - 7.1.3.1. Research-Grade Plasmid DNA
  - 7.1.3.2. GMP-Grade Plasmid DNA

8. Viral Vectors and Plasmid DNA Manufacturing Market - By Workflow

8.1. Overview
- 8.1.1. Segment Share Analysis, By Workflow, 2025 & 2033 (%)
- 8.1.2. Upstream Manufacturing
- 8.1.3. Downstream Manufacturing

9. Viral Vectors and Plasmid DNA Manufacturing Market - By Application

9.1. Overview
- 9.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
- 9.1.2. Cell Therapy
- 9.1.3. Gene Therapy
- 9.1.4. Vaccine Development
- 9.1.5. Others

10. Viral Vectors and Plasmid DNA Manufacturing Market - By End-Use

10.1. Overview
- 10.1.1. Segment Share Analysis, By End-Use, 2025 & 2033 (%)
- 10.1.2. Pharmaceutical & Biotechnology Companies
- 10.1.3. CDMOs
- 10.1.4. Academic & Research Institutes
- 10.1.5. Others

11. Viral Vectors and Plasmid DNA Manufacturing Market- By Geography

11.1. Introduction
- 11.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
11.2. North America
- 11.2.1. Overview
- 11.2.2. Viral Vectors and Plasmid DNA Manufacturing Key Manufacturers in North America
- 11.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 11.2.4. North America Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.2.5. North America Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
- 11.2.6. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.2.7. North America Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.2.8. U.S.
  - 11.2.8.1. Overview
  - 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
  - 11.2.8.4. U.S. Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
  - 11.2.8.5. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 11.2.8.6. U.S. Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.2.9. Canada
  - 11.2.9.1. Overview
  - 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
  - 11.2.9.4. Canada Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
  - 11.2.9.5. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 11.2.9.6. Canada Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.3. Europe
- 11.3.1. Overview
- 11.3.2. Viral Vectors and Plasmid DNA Manufacturing Key Manufacturers in Europe
- 11.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 11.3.4. Europe Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.3.5. Europe Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
- 11.3.6. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.7. Europe Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.3.8. Germany
  - 11.3.8.1. Overview
  - 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
  - 11.3.8.4. Germany Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
  - 11.3.8.5. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 11.3.8.6. Germany Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.3.9. UK
  - 11.3.9.1. Overview
  - 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.3.9.3. UK Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
  - 11.3.9.4. UK Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
  - 11.3.9.5. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 11.3.9.6. UK Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.3.10. France
  - 11.3.10.1. Overview
  - 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.3.10.3. France Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
  - 11.3.10.4. France Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
  - 11.3.10.5. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 11.3.10.6. France Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.3.11. Italy
  - 11.3.11.1. Overview
  - 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.3.11.3. Italy Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
  - 11.3.11.4. Italy Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
  - 11.3.11.5. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 11.3.11.6. Italy Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.3.12. Spain
  - 11.3.12.1. Overview
  - 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.3.12.3. Spain Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
  - 11.3.12.4. Spain Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
  - 11.3.12.5. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 11.3.12.6. Spain Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.3.13. The Netherlands
  - 11.3.13.1. Overview
  - 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.3.13.3. The Netherlands Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
  - 11.3.13.4. The Netherlands Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
  - 11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 11.3.13.6. The Netherlands Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.3.14. Sweden
  - 11.3.14.1. Overview
  - 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.3.14.3. Sweden Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
  - 11.3.14.4. Sweden Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
  - 11.3.14.5. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 11.3.14.6. Sweden Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.3.15. Russia
  - 11.3.15.1. Overview
  - 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.3.15.3. Russia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
  - 11.3.15.4. Russia Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
  - 11.3.15.5. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 11.3.15.6. Russia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.3.16. Poland
  - 11.3.16.1. Overview
  - 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.3.16.3. Poland Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
  - 11.3.16.4. Poland Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
  - 11.3.16.5. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 11.3.16.6. Poland Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.3.17. Rest of Europe
  - 11.3.17.1. Overview
  - 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.3.17.3. Rest of the Europe Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
  - 11.3.17.4. Rest of the Europe Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
  - 11.3.17.5. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 11.3.17.6. Rest of the Europe Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.4. Asia Pacific (APAC)
- 11.4.1. Overview
- 11.4.2. Viral Vectors and Plasmid DNA Manufacturing Key Manufacturers in Asia Pacific
- 11.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 11.4.4. APAC Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.4.5. APAC Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
- 11.4.6. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.7. APAC Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.4.8. China
  - 11.4.8.1. Overview
  - 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.4.8.3. China Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
  - 11.4.8.4. China Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
  - 11.4.8.5. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 11.4.8.6. China Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.4.9. India
  - 11.4.9.1. Overview
  - 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.4.9.3. India Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
  - 11.4.9.4. India Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
  - 11.4.9.5. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 11.4.9.6. India Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.4.10. Japan
  - 11.4.10.1. Overview
  - 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
  - 11.4.10.4. Japan Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
  - 11.4.10.5. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 11.4.10.6. Japan Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.4.11. South Korea
  - 11.4.11.1. Overview
  - 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
  - 11.4.11.4. South Korea Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
  - 11.4.11.5. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 11.4.11.6. South Korea Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.4.12. Australia
  - 11.4.12.1. Overview
  - 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
  - 11.4.12.4. Australia Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
  - 11.4.12.5. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 11.4.12.6. Australia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.4.13. Indonesia
  - 11.4.13.1. Overview
  - 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
  - 11.4.13.4. Indonesia Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
  - 11.4.13.5. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 11.4.13.6. Indonesia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.4.14. Thailand
  - 11.4.14.1. Overview
  - 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.4.14.3. Thailand Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
  - 11.4.14.4. Thailand Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
  - 11.4.14.5. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 11.4.14.6. Thailand Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.4.15. Philippines
  - 11.4.15.1. Overview
  - 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
  - 11.4.15.4. Philippines Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
  - 11.4.15.5. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 11.4.15.6. Philippines Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.4.16. Rest of APAC
  - 11.4.16.1. Overview
  - 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
  - 11.4.16.4. Rest of APAC Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
  - 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 11.4.16.6. Rest of APAC Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.5. Latin America (LATAM)
- 11.5.1. Overview
- 11.5.2. Viral Vectors and Plasmid DNA Manufacturing Key Manufacturers in Latin America
- 11.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 11.5.4. LATAM Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.5.5. LATAM Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
- 11.5.6. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.5.7. LATAM Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.5.8. Brazil
  - 11.5.8.1. Overview
  - 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
  - 11.5.8.4. Brazil Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
  - 11.5.8.5. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 11.5.8.6. Brazil Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.5.9. Mexico
  - 11.5.9.1. Overview
  - 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
  - 11.5.9.4. Mexico Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
  - 11.5.9.5. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 11.5.9.6. Mexico Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.5.10. Argentina
  - 11.5.10.1. Overview
  - 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
  - 11.5.10.4. Argentina Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
  - 11.5.10.5. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 11.5.10.6. Argentina Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.5.11. Colombia
  - 11.5.11.1. Overview
  - 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
  - 11.5.11.4. Colombia Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
  - 11.5.11.5. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 11.5.11.6. Colombia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.5.12. Rest of LATAM
  - 11.5.12.1. Overview
  - 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
  - 11.5.12.4. Rest of LATAM Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
  - 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.6. Middle East and Africa (MEA)
- 11.6.1. Overview
- 11.6.2. Viral Vectors and Plasmid DNA Manufacturing Key Manufacturers in Middle East and Africa
- 11.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 11.6.4. MEA Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.6.5. MEA Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
- 11.6.6. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.6.7. MEA Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.6.8. Saudi Arabia
  - 11.6.8.1. Overview
  - 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
  - 11.6.8.4. Saudi Arabia Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
  - 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.6.9. United Arab Emirates
  - 11.6.9.1. Overview
  - 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
  - 11.6.9.4. United Arab Emirates Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
  - 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.6.10. Israel
  - 11.6.10.1. Overview
  - 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
  - 11.6.10.4. Israel Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
  - 11.6.10.5. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 11.6.10.6. Israel Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.6.11. Turkey
  - 11.6.11.1. Overview
  - 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
  - 11.6.11.4. Turkey Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
  - 11.6.11.5. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 11.6.11.6. Turkey Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.6.12. Algeria
  - 11.6.12.1. Overview
  - 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
  - 11.6.12.4. Algeria Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
  - 11.6.12.5. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 11.6.12.6. Algeria Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.6.13. Egypt
  - 11.6.13.1. Overview
  - 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
  - 11.6.13.4. Egypt Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
  - 11.6.13.5. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 11.6.13.6. Egypt Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.6.14. Rest of MEA
  - 11.6.14.1. Overview
  - 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
  - 11.6.14.4. Rest of MEA Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
  - 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 11.6.14.6. Rest of MEA Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)

12. Key Vendor Analysis- Viral Vectors and Plasmid DNA Manufacturing Industry

12.1. Competitive Dashboard
- 12.1.1. Competitive Benchmarking
- 12.1.2. Competitive Positioning
12.2. Company Profiles
- 12.2.1. Lonza
- 12.2.2. Aldevron
- 12.2.3. ViroCell Biologics
- 12.2.4. Andelyn Biosciences
- 12.2.5. VGXI, Inc.
- 12.2.6. Avid Bioservices
- 12.2.7. Thermo Fisher Scientific
- 12.2.8. WuXi Biologics
- 12.2.9. Catalent Inc.
- 12.2.10. AGC Biologics
- 12.2.11. Fujifilm Diosynth Biotechnologies
- 12.2.12. Cobra Biologics
- 12.2.13. Oxford Biomedica
- 12.2.14. Takara Bio
- 12.2.15. Charles River Laboratories
- 12.2.16. Merck KGaA
- 12.2.17. Sartorius
- 12.2.18. GenScript Biotech
- 12.2.19. RegenxBio Inc.
- 12.2.20. SIRION Biotech
- 12.2.21. Others